Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9)

Resource type
Journal Article
Authors/contributors
Title
Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9)
Publication
Leukemia
Date
2023
Volume
37
Issue
9
Pages
1933-1938
Journal Abbr
Leukemia
Accessed
4/1/25, 9:58 AM
ISSN
0887-6924
Library Catalog
PubMed Central
Extra
PMID: 37460673 PMCID: PMC10457191
Citation
Cesaro, S., Mikulska, M., Hirsch, H. H., Styczynski, J., Meylan, S., Cordonnier, C., Navarro, D., von Lilienfeld-Toal, M., Mehra, V., Marchesi, F., Besson, C., Masculano, R. C., Beutel, G., Einsele, H., Maertens, J., de la Camara, R., Ljungman, P., & Pagano, L. (2023). Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9). Leukemia, 37(9), 1933–1938. https://doi.org/10.1038/s41375-023-01938-5
GUIDELINES
Link to this record